Nasopharyngeal SARS-CoV-2 may not be dispersed by a high-flow nasal cannula

• Published in: Scientific reports Vol. 13; no. 1; pp. 2669 - 6
• Main Authors: Suzuki, Tetsuya, Morioka, Shinichiro, Yamamoto, Kei, Saito, Sho, Iida, Shun, Teruya, Katsuji, Takasaki, Jin, Hojo, Masayuki, Hayakawa, Kayoko, Kutsuna, Satoshi, Miyamoto, Sho, Ozono, Seiya, Suzuki, Tadaki, Kodama, Eiichi N., Ohmagari, Norio
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 15.02.2023; Nature Publishing Group; Nature Portfolio
• Subjects: 631/326/171/1281; 631/326/596/4130; 692/699/255; Air sampling; Cannula; Coronaviruses; COVID-19; COVID-19 - therapy; Gelatin; Humanities and Social Sciences; Humans; Mechanical ventilation; multidisciplinary; Nasopharynx; Noninvasive Ventilation - methods; Oxygen Inhalation Therapy - methods; Oxygenation; Respiratory Aerosols and Droplets; Respiratory Insufficiency - therapy; Ribonucleic acid; RNA; RNA viruses; SARS-CoV-2; Science; Science (multidisciplinary); Severe acute respiratory syndrome coronavirus 2; Viruses

A high-flow nasal cannula (HFNC) therapy plays a significant role in providing respiratory support to critically ill patients with coronavirus disease 2019 (COVID-19); however, the dispersion of the virus owing to aerosol generation is a matter of concern. This study aimed to evaluate if HFNC disper...